IQGAP1 and IQGAP2 are Reciprocally Altered in Hepatocellular Carcinoma

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  White, Colin D ^a   Khurana, Hema ^a   Gnatenko, Dmitri V ^b   Li, Zhigang ^a   Odze, Robert D ^a   Sacks, David B ^a   Schmidt, Valentina A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; GENOMIC DNA; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 2; MESSENGER RNA; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; DNA; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IQGAP2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; PROTEIN EXPRESSION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; BIOPSY; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RAS GTPASE-ACTIVATING PROTEINS; TUMOR CELLS, CULTURED;

EID: 77958137062     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-125     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94(2):153-156. 10.1002/ijc.1440, 11668491.
2. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006, 6(9):674-687. 10.1038/nrc1934, 16929323.
3. Thomas M. Molecular targeted therapy for hepatocellular carcinoma. J Gastroenterol 2009, 44(19):136-141. 10.1007/s00535-008-2252-z, 19148808.
4. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002, 31(4):339-346. 10.1038/ng0802-339, 12149612.
5. Brown MD, Sacks DB. IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol 2006, 16(5):242-249. 10.1016/j.tcb.2006.03.002, 16595175.
6. Schmidt VA, Chiariello CS, Capilla E, Miller F, Bahou WF. Development of hepatocellular carcinoma in Iqgap2 deficient mice is IQGAP1 dependent. Mol Cell Biol 2008, 28(5):1489-1502. 10.1128/MCB.01090-07, 2258764, 18180285.
7. Schmidt VA, Scudder L, Devoe CE, Bernards A, Cupit LD, Bahou WF. IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization. Blood 2003, 101(8):3021-3028. 10.1182/blood-2002-09-2807, 12515716.
8. Wang S, Watanabe T, Noritake J, Fukata M, Yoshimura T, Itoh N, Harada T, Nakagawa M, Matsuura Y, Arimura N, et al. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci 2007, 120(4):567-577. 10.1242/jcs.03356, 17244649.
9. Djinovic Carugo K, Banuelos S, Saraste M. Crystal structure of a calponin homology domain. Nat Struct Biol 1997, 4(3):175-179. 10.1038/nsb0397-175, 9164454.
10. Roy M, Li Z, Sacks DB. IQGAP1 binds ERK2 and modulates its activity. J Biol Chem 2004, 279(17):17329-17337. 10.1074/jbc.M308405200, 14970219.
11. Roy M, Li Z, Sacks DB. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol Cell Biol 2005, 25(18):7940-7952. 10.1128/MCB.25.18.7940-7952.2005, 1234344, 16135787.
12. Fukata M, Kuroda S, Nakagawa M, Kawajiri A, Itoh N, Shoji I, Matsuura Y, Yonehara S, Fujisawa H, Kikuchi A, et al. Cdc42 and Rac1 regulate the interaction of IQGAP1 with β-catenin. J Biol Chem 1999, 274(37):26044-26050. 10.1074/jbc.274.37.26044, 10473551.
13. Briggs MW, Li Z, Sacks DB. IQGAP1-mediated stimulation of transcriptional coactivation by β-catenin is modulated by calmodulin. J Biol Chem 2002, 277(9):7453-7465. 10.1074/jbc.M104315200, 11734550.
14. Kuroda S, Fukata M, Nakagawa M, Fujii K, Nakamura T, Ookubo T, Izawa I, Nagase T, Nomura N, Tani H, et al. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cell-cell adhesion. Science 1998, 281(5378):832-835. New York, NY, 10.1126/science.281.5378.832, 9694656.
15. Li Z, Kim SH, Higgins JM, Brenner MB, Sacks DB. IQGAP1 and calmodulin modulate E-cadherin function. J Biol Chem 1999, 274(53):37885-37892. 10.1074/jbc.274.53.37885, 10608854.
16. Watanabe T, Wang S, Noritake J, Sato K, Fukata M, Takefuji M, Nakagawa M, Izumi N, Akiyama T, Kaibuchi K. Interaction with IQGAP1 links APC to Rac1, Cdc42 and actin filaments during cell polarization and migration. Dev Cell 2004, 7(6):871-883. 10.1016/j.devcel.2004.10.017, 15572129.
17. Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA. IQGAP1 regulates cell proliferation through a novel Cdc42-mTOR pathway. J Cell Sci 2009, 122(12):2024-2033. 10.1242/jcs.044644, 2723156, 19454477.
18. Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita JB, Daviet L, Camonis J, D'Souza-Schorey C, Chavrier P. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol 2008, 181(6):985-998. 10.1083/jcb.200709076, 2426946, 18541705.
19. Mataraza JM, Briggs MW, Li Z, Entwistle A, Ridley AJ, Sacks DB. IQGAP1 promotes cell motility and invasion. J Biol Chem 2003, 278(42):41237-41245. 10.1074/jbc.M304838200, 12900413.
20. Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K. IQGAP1: a key regulator of adhesion and migration. J Cell Sci 2005, 118(10):2085-2092. 10.1242/jcs.02379, 15890984.
21. Jadeski L, Mataraza JM, Jeong HW, Li Z, Sacks DB. IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells. J Biol Chem 2008, 283(2):1008-1017. 10.1074/jbc.M708466200, 17981797.
22. White CD, Brown MD, Sacks DB. IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett 2009, 583(12):1817-1824. 10.1016/j.febslet.2009.05.007, 2743239, 19433088.
23. Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int J Cancer 2008, 122(5):1040-1046. 10.1002/ijc.23181, 17957782.
24. Ho YD, Joyal JL, Li Z, Sacks DB. IQGAP1 integrates Ca2+/calmodulin and Cdc42 signaling. J Biol Chem 1999, 274(1):464-470. 10.1074/jbc.274.1.464, 9867866.
25. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996, 6(10):986-994. 10.1101/gr.6.10.986, 8908518.
26. Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, Bahou WF. Platelets express steroidogenic 17β-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Thromb Haemost 2005, 94(2):412-421.
27. Titze S, Peters H, Wahrisch S, Harder T, Guse K, Buske A, Tinschert S, Harder A. Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients. Eur J Hum Genet 2010, 18(1):81-87. 10.1038/ejhg.2009.129, 19639020.
28. Aranyi T, Varadi A, Simon I, Tusnady GE. The BiSearch web server. BMC Bioinformatics 2006, 7(1):431. 10.1186/1471-2105-7-431, 1609187, 17022803.
29. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M, Tanabe KK. Epithelial to mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 2008, 68(7):2391-2399. 10.1158/0008-5472.CAN-07-2460, 18381447.
30. Christofori G, Semb H. The role of the cell adhesion molecule E-cadherin as a tumour suppressor gene. Trends Biochem Sci 1999, 24(2):73-76. 10.1016/S0968-0004(98)01343-7, 10098402.
31. Lee JS, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 2002, 35(5):1134-1143. 10.1053/jhep.2002.33165, 11981763.
32. Varma V, Cohen C. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol 2004, 11(5):239-249. 10.1097/01.pap.0000131822.31576.9d, 15322490.
33. Wang HL, Anatelli F, Zhai QJ, Adley B, Chuang ST, Yang XJ. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch Pathol Lab Med 2008, 132(11):1723-1728.
34. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and α-fetoprotein. Am J Surg Pathol 2002, 26(8):978-988. 10.1097/00000478-200208000-00002, 12170084.
35. Morrison C, Marsh W, Frankel WL. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002, 15(12):1279-1287. 10.1097/01.MP.0000037312.69565.24, 12481008.
36. Baumhoer D, Tornillo L, Stadlmann S, Roncalli M, Diamantis EK, Terracciano LM. Glypican-3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am J Clin Pathol 2008, 129(6):899-906. 10.1309/HCQWPWD50XHD2DW6, 18480006.
37. Tsubota A, Matsumoto K, Mogushi K, Nariai K, Namiki Y, Hoshina S, Hano H, Tanaka H, Saito H, Tada N. IQGAP1 and vimentin are key regulator genes in naturally occurring hepatotumorigenesis induced by oxidative stress. Carcinogenesis 2010, 31(3):504-511. 10.1093/carcin/bgp313, 20015863.
38. Feng Q, Stern JE, Hawes SE, Lu H, Jiang M, Kiviat NB. DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Exp Mol Pathol 2010, 88(2):287-292. 10.1016/j.yexmp.2010.01.002, 20079733.
39. Archer KJ, Mas VR, Maluf DG, Fisher RA. High throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics 2010, 283(4):341-349. 10.1007/s00438-010-0522-y, 20165882.
40. Liao YL, Sun YM, Chau GY, Chau YP, Lai TC, Wang JL, Horng JT, Hsiao M, Tsou AP. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 2008, 27(1):5578-5589. 10.1038/onc.2008.168, 18504433.
41. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16(4):168-174. 10.1016/S0168-9525(99)01971-X, 10729832.
42. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16(1):r50-r59. 10.1093/hmg/ddm018, 17613547.
43. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003, 163(3):1101-1107. 1868243, 12937151.
44. Brakensiek K, Wingen LU, Langer F, Kreipe H, Lehmann U. Quantitative high resolution CpG island mapping with pyrosequencing reveals disease specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia. Clin Chem 2007, 53(1):17-23. 10.1373/clinchem.2007.072629, 17095538.
45. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM. Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 2006, 94(4):561-568. 10.1038/sj.bjc.6602972, 2361183, 16449996.
46. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31(5):766-776. 10.1093/carcin/bgp250, 19843643.